During the past decade, MJHS Institute for Innovation in Palliative Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MJHS Institute for Innovation in Palliative Care" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "New York Headache Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MJHS Institute for Innovation in Palliative Care" are "Cancer" (1 trials), "Constipation" (1 trials), "Migraine Disorders" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "MJHS Institute for Innovation in Palliative Care" in a lesser frequency.

Most popular intervention types in "MJHS Institute for Innovation in Palliative Care" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Naloxegol" (1 trials), "Placebo" (1 trials) and "non-invasive transcranial direct current stimulation (tDCS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "MJHS Institute for Innovation in Palliative Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MJHS Institute for Innovation in Palliative Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MJHS Institute for Innovation in Palliative Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MJHS Institute for Innovation in Palliative Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".